loteprednol etabonate 2 MG/ML Ophthalmic Suspension [Alrex]
- RxCUI
- 213262
- RxNorm name
- loteprednol etabonate 2 MG/ML Ophthalmic Suspension [Alrex]
- Display name
- loteprednol etabonate 2 MG/ML Ophthalmic Suspension [Alrex]
- Full name
- loteprednol etabonate 2 MG/ML Ophthalmic Suspension [Alrex]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alrex | LOTEPREDNOL ETABONATE | Bausch & Lomb Incorporated | 21c76da0-50a1-41c0-91b8-8cc4dcc27f60 | 2022-03-31 | Warnings, Adverse reactions | 213262 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 21c76da0-50a1-41c0-91b8-8cc4dcc27f60 | Alrex 0.2 % Ophthalmic Suspension [PSN] · loteprednol etabonate 2 MG/ML Ophthalmic Suspension [Alrex] [SBD] · Alrex 0.2 % Ophthalmic Suspension [SY] · Alrex 2 MG/ML Ophthalmic Suspension [SY] | 4 | 14 | Alrex ® (loteprednol etabonate ophthalmic suspension, 0.2%) STERILE OPHTHALMIC SUSPENSION | 20220331 |
| cf290d54-26a1-4d22-8cb8-852bdc7b5280 | Alrex 0.2 % Ophthalmic Suspension [PSN] · loteprednol etabonate 2 MG/ML Ophthalmic Suspension [Alrex] [SBD] · Alrex 0.2 % Ophthalmic Suspension [SY] · Alrex 2 MG/ML Ophthalmic Suspension [SY] | 4 | 2 | ALREX loteprednol etabonate ophthalmic suspension, 0.2% | 20120918 |
| 95188fb4-03b6-46ac-a601-41cb82ebde40 | Alrex 0.2 % Ophthalmic Suspension [PSN] · loteprednol etabonate 2 MG/ML Ophthalmic Suspension [Alrex] [SBD] · Alrex 0.2 % Ophthalmic Suspension [SY] · Alrex 2 MG/ML Ophthalmic Suspension [SY] | 4 | 1 | ALREX loteprednol etabonate ophthalmic suspension, 0.2% | 20120910 |